US-based biotechnology company Ocugen has announced its plan to establish a research and development (R&D) center in Telangana with an aim to focus on developing cutting-edge modifier gene therapies and regenerative cell therapy.
The announcement was made after IT and Industries Minister K. T. Rama Rao met with the chairman, CEO and co-founder of Ocugen Inc., Dr. Shankar Musunuri and his team.
Minister K.T. Rama Rao said, “This is a testament to the vibrant biotech industry and a strong academic base in the state that has attracted both local and international players to establish research and development centers.”
Based out of Pennsylvania in United States, Ocugen, Inc. focuses on discovering, developing, and commercializing new treatment options to improve health and offer hope for patients across the globe through its innovations.
“We look forward to expanding operations in India and beginning to transform Ocugen into a truly global organization as we pursue new approaches to medicine said Dr. Shankar Musunuri.
 center in Telangana with an...){kind=link}